Dr. Alok Kanojia (Dr. K)

speaker

1,658 appearances 5 recordings 3 series first heard Sep 2025 last heard 27 May

Dr. Alok Kanojia (Dr. K)’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 4 in all, peaking in Oct 2025 with 2.

Appearances

newest first · ▶ plays the moment

HealthyGamerGG · How Psychedelics Unlock Your Brain’s “Edit Mode” · 13 Oct 2025 podcast

So this is the other point that I'm sort of making is that like when we say psychedelics are good for your mental health, which psychedelic and which problem you have with your mental health actually becomes really important.

So if you're going to, you know, the Amazon and you're doing ayahuasca because you're depressed, you may not get much benefit from that.

Whereas if you have major depressive disorder, psilocybin is sort of like the right medicine to use.

And now here's what's really cool.

So if we're talking about treatment resistant depression or recurrent major depressive disorder, this is where we start to see some cool stuff.

So the first thing is that if we're talking about simple depression, ayahuasca seems to be not very effective.

But if you have treatment resistant depression, now we're seeing larger effect sizes.

And we're seeing effect sizes as well for psilocybin.

So this is what's actually really cool about psychedelics.

And I think this is why people like myself who are psychiatrists get really excited.

So we have this entity called treatment-resistant depression.

And the whole point of treatment-resistant depression is that it is resistant to treatment.

So if I try to treat treatment-resistant depression, it doesn't work.

So there's a class of patients that I've absolutely worked with who have depression that doesn't seem to be treatable by things like antidepressant medication.

The really cool thing is that some of these psychedelic medications or some of these psychedelics seem to help the people who have difficulty benefiting from other sorts of treatments.

That's why it's really exciting.

So we're going to take another look at another table.

So this is a table that's looking at comparisons of the effects of psychedelics under different evaluation systems.

So now what we're doing, so I don't know if this kind of makes sense.

This graph, we're going to do Science 101, looking at a condition.

Showing 421–440 of 1,658 · page 22 of 83